Correction: The story has been corrected to reflect that Chipotle CEO Scott Boatwright does not mention a price increase.Chipotle Mexican Grill Inc. (NYSE:CMG) CEO Scott Boatwright was heard talking about the company’s core customers and their average household income.“We learned that 60% of our core users are over $100,000 a year in income,” Boatwright said in a viral video shared by X user @WallStreetApes. “That gives us confidence that we can lean into that group in a more meaningful way.”The remarks cam ...

Is Netflix's 10% Dip a Buying Opportunity or a Warning Sign? - 24/7 Wall St.[S&P 5006,978.20 +0.32%][Dow Jones50,411.70 +0.29%][Nasdaq 10025,294.80 +0.43%][Russell 20002,706.27 +0.72%][FTSE 10010,453.60 +0.76%][Nikkei 22558,341.70 +0.56%][Investing]# Is Netflix's 10% Dip a Buying Opportunity or a Warning Sign?### Quick ReadNetflix (NFLX) fell 12.32% year-to-date as EPS declined three consecutive quarters from $0.72 to $0.56.Netflix missed Q3 2025 earnings by 15.71% with $0.59 EPS versus $0.70 expected.Netfl ...

Tech giant's annual revenues surpassed $400 billion for the first time ...

The medical-device maker beats quarterly earnings expectations but offers a disappointing outlook for the current quarter. ...

Core Viewpoint - Halliburton Company is expected to report a decline in fourth-quarter earnings and revenue compared to the previous year [1][2] Financial Performance - Analysts predict Halliburton will report fourth-quarter earnings of 55 cents per share, down from 70 cents per share in the same period last year [1] - The consensus estimate for quarterly revenue is $5.41 billion, a decrease from $5.61 billion reported last year [1] Stock Performance - Halliburton's shares fell by 1.6%, closing at $32.06 [2] - The company has beaten analyst revenue estimates in three consecutive quarters but only in four of the last ten quarters overall [2] Analyst Ratings - Piper Sandler maintained a Neutral rating and raised the price target from $29 to $30 [3] - TD Cowen maintained a Buy rating and increased the price target from $38 to $39 [3] - Susquehanna maintained a Positive rating and raised the price target from $29 to $36 [3] - Evercore ISI Group downgraded the stock from Outperform to In-Line while raising the price target from $28 to $35 [3] - Barclays maintained an Equal-Weight rating and increased the price target from $25 to $30 [3]

Core Insights - Moderna, Inc. is a biotechnology company focused on messenger RNA therapeutics and vaccines, currently valued at $15.9 billion [1] Financial Performance - Analysts expect Moderna to report a loss of $2.79 per share for Q4 2025, a decrease of 11.6% from $2.50 per share in the same quarter last year [2] - For the full year, the expected loss per share is $7.93, which is an increase of 10.6% from $8.87 in fiscal 2024, and a further rise to $6.88 is anticipated in fiscal 2026 [3] Stock Performance - Over the past 52 weeks, Moderna's stock has increased by 13.2%, underperforming the S&P 500 Index's gains of 16.7%, but outperforming the Health Care Select Sector SPDR Fund's returns of 11.7% [4] - The underperformance is attributed to declining demand for COVID vaccines, with expectations of a revenue decrease of 20% to 40% due to lower global vaccination rates [5] Recent Developments - On November 6, 2025, Moderna's shares rose over 3% after reporting Q3 results, with a loss per share of $0.51, significantly better than the expected loss of $2.15, and revenue of $1 billion, exceeding forecasts of $860.1 million [6] Analyst Ratings - The consensus opinion on Moderna stock is cautious, with a "Hold" rating from 24 analysts; two recommend "Strong Buy," 19 suggest "Hold," one advises "Moderate Sell," and two recommend "Strong Sell" [7] - Currently, Moderna trades above its mean price target of $35.15, with a Street-high price target of $135 indicating a potential upside of 243% [7]

Group 1 - U.S. equity funds experienced significant inflows of $28.18 billion in the week ending January 14, marking the largest weekly net purchase since October 1, reversing the previous week's net sales of $26.02 billion [2][3] - The fourth-quarter earnings season is expected to show a profit growth of 10.81% for U.S. large- and mid-cap companies, with the technology sector leading at a forecasted increase of 19.32% [2] - U.S. large-cap equity funds attracted a net inflow of $14.04 billion, while small-cap funds saw net investments of $579 million, and mid-cap funds experienced outflows of $1.91 billion [3] Group 2 - Bond funds recorded inflows of $10.12 billion, the highest weekly amount since October 8, with general domestic taxable fixed income funds leading at $3.23 billion [4] - Investors divested $75.72 billion from money market funds after a combined net purchase of $134.94 billion in the previous two weeks [6]

Group 1 - PNC Financial Services Group is set to release its fourth-quarter earnings on January 16, with expected earnings of $4.21 per share, an increase from $3.77 per share in the same period last year [1] - The consensus estimate for PNC's quarterly revenue is $5.95 billion, up from $5.57 billion reported last year [1] - On January 5, PNC declared a dividend of $1.70 on common stock [1] Group 2 - PNC Financial shares closed at $212.32, reflecting a decrease of 0.1% [2] - Analysts have provided various ratings and price targets for PNC stock, with TD Cowen maintaining a Buy rating and raising the price target from $235 to $250 [3] - Barclays maintained an Overweight rating and increased the price target from $235 to $271 [3] - Truist Securities maintained a Hold rating and raised the price target from $210 to $229 [3] - Keefe, Bruyette & Woods maintained a Market Perform rating and increased the price target from $215 to $228 [3] - Oppenheimer maintained an Outperform rating and raised the price target from $231 to $240 [3]

Core Viewpoint - The Bank of New York Mellon Corporation reported strong earnings for Q4 2025, but projects a slowdown in revenue growth for 2026, impacting stock performance [1][2][5] Financial Performance - BNY Mellon achieved an earnings per share (EPS) of $2.02, exceeding the estimated $1.97 [1][5] - The company reported revenue of approximately $5.18 billion, surpassing the anticipated $5.15 billion [1][5] Future Projections - The bank has projected a slowdown in revenue growth for 2026, which may be contributing to the decline in stock price [2][5] - CEO Robin Vince announced an increase in medium-term performance targets, raising pre-tax margin and return on tangible common equity by 5 percentage points each, now set at 38% and 28% respectively [2] Market Valuation - BNY Mellon has a price-to-earnings (P/E) ratio of approximately 16.24, indicating how the market values its earnings [3][5] - The price-to-sales ratio is about 2.08, reflecting the company's market value relative to its sales [3] Cash Flow and Financial Ratios - The enterprise value to sales ratio is notably low at 0.39, suggesting a potentially undervalued position in terms of sales [3] - The enterprise value to operating cash flow ratio stands at 5.14, indicating cash flow efficiency [4] - The earnings yield is 6.16%, showing the return on investment relative to its share price [4] - The debt-to-equity ratio is 1.17, indicating the company's financial leverage [4] - The current ratio is 0.50, which may suggest potential liquidity concerns [4][5]

Core Viewpoint - AZZ Inc. is set to release its third-quarter earnings on January 7, 2025, with expectations of increased earnings and revenue compared to the previous year [1]. Earnings Expectations - Analysts predict AZZ will report earnings of $1.49 per share, an increase from $1.39 per share in the same quarter last year [1]. - The consensus estimate for quarterly revenue is $419.47 million, up from $403.65 million a year earlier [1]. Stock Performance - AZZ shares rose by 2.4%, closing at $109.74 on the previous Friday [2]. Analyst Ratings - Wells Fargo analyst Timna Tanners maintained an Overweight rating, lowering the price target from $128 to $121 [3]. - B. Riley Securities analyst Lucas Pipes maintained a Buy rating, raising the price target from $131 to $140 [3]. - Evercore ISI Group analyst Stephen Richardson maintained an Outperform rating, increasing the price target from $90 to $108 [3]. - Sidoti & Co. analyst John Franzreb downgraded the stock from Buy to Neutral with a price target of $101 [3]. - Roth MKM analyst Gerry Sweeney initiated coverage with a Buy rating and a price target of $108 [3].